<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889251/" ref="ordinalpos=2951&amp;ncbi_uid=5702977&amp;link_uid=PMC3889251" image-link="/pmc/articles/PMC3889251/figure/Fig1/" class="imagepopup">Fig. 1.  From: Inhibition of CK2 binding to BMPRIa induces C2C12 differentiation into osteoblasts and adipocytes. </a></div><br /><div class="p4l_captionBody">BMP2 signaling pathway resulting in osteogenesis or adipogenesis. <b>a</b> Ligand binding to BMPRIa and BMPRII results in the release of CK2, followed by phosphorylation of BMPRIa by a constitutively active BMPRII, leading to signaling. <b>b</b> Signaling via Smad1, 5, and 8, ERK, PI3K, JNK, p38, and NF-kB results in osteogenesis. <b>c</b> Activation of Smad1, 5, and 8 and p38 pathways are implicated in adipogenesis</div></div>